<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guk DA</submitter><funding>Russian Science Foundation</funding><pagination>3340</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9964323</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(4)</volume><pubmed_abstract>The search for new anticancer drugs based on biogenic metals, which have weaker side effects compared to platinum-based drugs, remains an urgent task in medicinal chemistry. Titanocene dichloride, a coordination compound of fully biocompatible titanium, has failed in pre-clinical trials but continues to attract the attention of researchers as a structural framework for the development of new cytotoxic compounds. In this study, a series of titanocene (IV) carboxylate complexes, both new and those known from the literature, was synthesized, and their structures were confirmed by a complex of physicochemical methods and X-ray diffraction analysis (including one previously unknown structure based on perfluorinated benzoic acid). The comprehensive comparison of three approaches for the synthesi</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>New Titanocene (IV) Dicarboxylates with Potential Cytotoxicity: Synthesis, Structure, Stability and Electrochemistry.</pubmed_title><pmcid>PMC9964323</pmcid><funding_grant_id>22-73-00004</funding_grant_id><pubmed_authors>Gandalipov ER</pubmed_authors><pubmed_authors>Gibadullina KR</pubmed_authors><pubmed_authors>Burlutskiy RO</pubmed_authors><pubmed_authors>Tafeenko VA</pubmed_authors><pubmed_authors>Guk DA</pubmed_authors><pubmed_authors>Shtil AA</pubmed_authors><pubmed_authors>Moiseeva AA</pubmed_authors><pubmed_authors>Lyssenko KA</pubmed_authors><pubmed_authors>Pavlov KG</pubmed_authors><pubmed_authors>Beloglazkina EK</pubmed_authors></additional><is_claimable>false</is_claimable><name>New Titanocene (IV) Dicarboxylates with Potential Cytotoxicity: Synthesis, Structure, Stability and Electrochemistry.</name><description>The search for new anticancer drugs based on biogenic metals, which have weaker side effects compared to platinum-based drugs, remains an urgent task in medicinal chemistry. Titanocene dichloride, a coordination compound of fully biocompatible titanium, has failed in pre-clinical trials but continues to attract the attention of researchers as a structural framework for the development of new cytotoxic compounds. In this study, a series of titanocene (IV) carboxylate complexes, both new and those known from the literature, was synthesized, and their structures were confirmed by a complex of physicochemical methods and X-ray diffraction analysis (including one previously unknown structure based on perfluorinated benzoic acid). The comprehensive comparison of three approaches for the synthesi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T08:53:14.987Z</modification><creation>2025-04-04T08:53:14.987Z</creation></dates><accession>S-EPMC9964323</accession><cross_references><pubmed>36834751</pubmed><doi>10.3390/ijms24043340</doi></cross_references></HashMap>